1. |
Larsen CA, Dashwood RH. Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: minor role of hydrogen peroxide[J]. Biochem Biophys Res Commun, 2009, 389(3): 527-530.
|
2. |
Zhu BH, Zhan WH, Li ZR, et al. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis[J]. World J Gastroenterol, 2007, 13(8): 1162-1169.
|
3. |
Farabegoli F, Papi A, Bartolini G, et al. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line[J]. Phytomedicine, 2010, 17(5): 356-362.
|
4. |
Shankar S, Ganapathy S, Hingorani SR, et al. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer[J]. Front Biosci, 2008, 13(1): 440-452.
|
5. |
赵丽萍, 邵宛芳. 茶叶中EGCG功效研究进展[J]. 中国农学通报, 2007, 23(7): 143-147.
|
6. |
Suzuki Y, Miyoshi N, Isemura M. Health-promoting effect of green tea[J]. Proc Jpn Acad Ser B Phys Biol Sci, 2012,88(3): 88-101.
|
7. |
M Chacko S, Thambi PT, Kuttan R, et a1. Beneficial effects of green tea: a literature review[J]. Chin Med, 2010, 5(1): 13.
|
8. |
Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication[J]. Semin Diagn Pathol, 1993, 10(4): 302-313.
|
9. |
Zhu BH, Zhan WH, He YL, et al. Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism[J]. World J gastroenterol, 2009, 12(1): 82-85.
|
10. |
Wu H, Xin Y, Xiao Y, et al. Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts[J]. Cancer Biother Radiopharm, 2012, 27(3): 204-209.
|
11. |
Fraga A, Ribeiro R, Medeiros R. Tumor hypoxia: the role of HIF[J]. Actas Urol Esp, 2009, 33(9): 941- 951.
|
12. |
Nakayama K. Cellular signal transduction of the hypoxia response[J]. J Bio Chem, 2009, 146(6): 757-765.
|
13. |
Poon E, Harris AL, Ashcroft M. Targeting the hypoxia-inducible factor (HIF) pathway in cancer[J]. Expert Rev Mol Med, 2009, 27(2): 11- 26.
|
14. |
Jubb A, Hillan K. Expression of HIF-1 alpha in human tumours[J]. J Clin Pathol, 2005, 58(12): 1344.
|
15. |
Przybylski M. A review of the current research on the role of bFGF and VEGF in angiogenesis[J]. J Wound Care, 2009, 18(12): 516-519.
|
16. |
Appelmann I, Liersch R, Kessler T, et a1. Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy[J]. Recent Results Cancer Res, 2010, 180(3): 978-998.
|